1. Home
  2. OLMA vs ZVRA Comparison

OLMA vs ZVRA Comparison

Compare OLMA & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • ZVRA
  • Stock Information
  • Founded
  • OLMA 2006
  • ZVRA 2006
  • Country
  • OLMA United States
  • ZVRA United States
  • Employees
  • OLMA N/A
  • ZVRA N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLMA Health Care
  • ZVRA Health Care
  • Exchange
  • OLMA Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • OLMA 560.7M
  • ZVRA 467.6M
  • IPO Year
  • OLMA 2020
  • ZVRA 2015
  • Fundamental
  • Price
  • OLMA $10.48
  • ZVRA $10.25
  • Analyst Decision
  • OLMA Strong Buy
  • ZVRA Strong Buy
  • Analyst Count
  • OLMA 5
  • ZVRA 8
  • Target Price
  • OLMA $24.00
  • ZVRA $22.57
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • ZVRA 2.6M
  • Earning Date
  • OLMA 11-11-2025
  • ZVRA 11-11-2025
  • Dividend Yield
  • OLMA N/A
  • ZVRA N/A
  • EPS Growth
  • OLMA N/A
  • ZVRA N/A
  • EPS
  • OLMA N/A
  • ZVRA N/A
  • Revenue
  • OLMA N/A
  • ZVRA $62,020,000.00
  • Revenue This Year
  • OLMA N/A
  • ZVRA $336.43
  • Revenue Next Year
  • OLMA N/A
  • ZVRA $54.26
  • P/E Ratio
  • OLMA N/A
  • ZVRA N/A
  • Revenue Growth
  • OLMA N/A
  • ZVRA 161.81
  • 52 Week Low
  • OLMA $2.86
  • ZVRA $6.19
  • 52 Week High
  • OLMA $13.51
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 70.04
  • ZVRA 60.31
  • Support Level
  • OLMA $8.01
  • ZVRA $9.08
  • Resistance Level
  • OLMA $11.54
  • ZVRA $9.56
  • Average True Range (ATR)
  • OLMA 0.79
  • ZVRA 0.66
  • MACD
  • OLMA 0.14
  • ZVRA 0.27
  • Stochastic Oscillator
  • OLMA 72.61
  • ZVRA 77.96

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: